Opydo M, Wojtaszek M, Mosurek A, Burczyk G, et al. Targeting BCL-2 and PI3K signaling pathways enhances cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cells. Biochem Biophys Res Commun 2026;817:153752.
PMID: 41980559